VenoStent

Houston, TX · Founded 2015 · Privately Held (backing)

Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patients. VenoStent is based in Houston, TX and was founded in 2015. It has raised $22.8 million across 2 recorded rounds; the latest was a $10 million early-stage round in Apr 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$22.8M
Last round
Early Stage VC
Apr 2026

Who backs VenoStent?

30 investors
InvestorType
Y CombinatorOther
Alumni VenturesVenture capital
US National Science FoundationOther
MassChallenge—
National Institutes of HealthOther
NorwestVenture capital
Texas Medical CenterVenture capital
Kube VC—
Johnson & Johnson Innovation - JLABSOther
SNRVenture capital
+ 20 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

VenoStent investors

30 investors are on record for VenoStent, including Y Combinator, Alumni Ventures, US National Science Foundation and MassChallenge. By type, the record holds 10 venture capital firms. The early-stage round in Apr 2026 drew 29 investors.

Free account
More of VenoStent with a free account
  • ·The complete investor list: 30 names
  • ·Watch VenoStent: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like VenoStent. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View